• product_banner

2022 Latest Design Chikungunya Igm Test - Anti-human sFlt-1 Antibody, Mouse Monoclonal – Bioantibody

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Our purpose would be to offer good quality products at competitive price ranges, and top-notch support to clients around the whole world. We're ISO9001, CE, and GS certified and strictly adhere to their good quality specifications for Antigen Lateral Flow Test, Influenza A/B Antigen Test, Malaria, We never stop improving our technique and high quality to help keep up using the enhancement trend of this industry and meet your gratification effectively. In case you are intrigued in our items, please call us freely.
2022 Latest Design Chikungunya Igm Test - Anti-human sFlt-1 Antibody, Mouse Monoclonal – Bioantibody Detail:

Product details

General Information
Preeclampsia is a serious multi-system complication of pregnancy, occurring in 3 – 5 % of pregnancies, and it is one of the leading causes of maternal and perinatal morbidity and mortality worldwide.

Preeclampsia is defined as new-onset of hypertension and proteinuria after 20 weeks of gestation. The clinical presentation of preeclampsia and subsequent clinical course of the disease can vary tremendously, making prediction, diagnosis and assessment of disease progression difficult.

Angiogenic factors (sFlt-1 and PlGF) are proven to play an important role in the pathogenesis of preeclampsia and their concentrations in maternal serum are altered even before the onset of the disease making them a tool for prediction and aid in diagnosis of preeclampsia.

Properties

Pair Recommendation CLIA (Capture-Detection):
1E4-6 ~ 2A6-4
2A6-4 ~ 1E4-6
Purity >95% as determined by SDS-PAGE.
Buffer Formulation PBS, pH7.4.
Storage Store it under sterile conditions at -20℃ to -80℃ upon receiving.
Recommend to aliquot the protein into smaller quantities for optimal storage.

Competitive Comparison

DETAIL (1)
DETAIL (2)

Order Information

Product Name Cat. No Clone ID
sFlt-1 AB0029-1 1E4-6
AB0029-2 2A6-4
AB0029-3 2H1-5
AB0029-4 4D9-10

Note: Bioantibody can customized quantities per your need.

Citations

1.Stepan H , Geide A , Faber R . Soluble fms-like tyrosine kinase 1.[J]. N Engl J Med, 2004, 351(21):2241-2242.

2.Kleinrouweler C E , Wiegerinck M , Ris-Stalpers C , et al. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis.[J]. Bjog An International Journal of Obstetrics & Gynaecology, 2012, 119(7):778-787.


Product detail pictures:

2022 Latest Design Chikungunya Igm Test - Anti-human sFlt-1 Antibody, Mouse Monoclonal – Bioantibody detail pictures

2022 Latest Design Chikungunya Igm Test - Anti-human sFlt-1 Antibody, Mouse Monoclonal – Bioantibody detail pictures


Related Product Guide:

Fast and good quotations, informed advisers to help you choose the correct product that suits all your needs, a short production time, responsible quality control and different services for paying and shipping affairs for 2022 Latest Design Chikungunya Igm Test - Anti-human sFlt-1 Antibody, Mouse Monoclonal – Bioantibody , The product will supply to all over the world, such as: Turkmenistan, Turkey, Riyadh, We have a large share in global market. Our company has strong economic strength and offers excellent sale service. We have established faith, friendly, harmonious business relationship with customers in different countries. , such as Indonesia, Myanmar, Indi and other Southeast Asian countries and European, African and Latin American countries.
  • This company has a lot of ready-made options to choose and also could custom new program according to our demand, which is very nice to meet our needs.
    5 Stars By Lesley from Johor - 2018.02.21 12:14
    Timely delivery, strict implementation of the contract provisions of the goods, encountered special circumstances, but also actively cooperate, a trustworthy company!
    5 Stars By Karl from Israel - 2017.09.30 16:36
    Write your message here and send it to us